The MDH TB Prevention and Control Program prepares quarterly and annual reports summarizing the demographic and clinical characteristics of the cases of TB disease reported in Minnesota. These reports describe the epidemiology of TB in Minnesota, including the incidence of TB disease by county, age, race/ethnicity, country of origin, drug susceptibility patterns, and other factors. To request data, please see STD/HIV/TB Data and Presentation Request.
- Tuberculosis Quarterly Surveillance Report, July 1-Sept. 30, 2022
Quarterly summary of the epidemiology of the confirmed cases of TB disease reported to the Minnesota Department of Health from July 1 - Sept. 30, 2022. Updated 10/2022
- The Epidemiology of Tuberculosis in Minnesota, 2016-2020 (PDF)
Slide series that provides epidemiologic data on demographic and clinical characteristics of the cases of TB disease reported in Minnesota during this 5-year period.Updated 07/2022
- Tuberculosis Disease - Minnesota, 2021 (PDF)
Tuberculosis Disease - Minnesota, 2017-2021 (PDF)
Maps showing the number of TB cases by county of residence at time of reporting for 2021 and 2017-2021. Updated 07/2022
- Tuberculosis Cases by County, 2007-2021 (PDF)
Presents the number of cases of TB disease reported by county in Minnesota for the 15-year period from 2007 through 2021. Updated 2/2022
- Incidence, Prevalence, and Drug Resistance by County, 2016 (PDF)
Provides the number of incident and prevalent cases of TB disease by county in Minnesota during 2016, including data on the percentage of cases with drug resistance. This report is updated in May of the following year.
- Antimicrobial Susceptibility of Selected Pathogens in Minnesota
This "antibiogram" provides drug-specific data on the prevalence of antimicrobial susceptibilities of selected pathogens, including Mycobacterium tuberculosis, in Minnesota. Past reports date back to 1998.
- Annual Summary of Tuberculosis Reported to the Minnesota Department of Health
MDH collects disease surveillance information on certain communicable diseases, including TB to determine disease impact, assess trends in disease occurrence, characterize affected populations, prioritize disease control efforts, and evaluate disease prevention strategies.
- National TB Surveillance Reports
Link to national surveillance data on TB disease in the United States, as reported by the Centers for Disease Control and Prevention.
- NCHHSTP Atlas
Access data reported to CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). Use HIV, STD, hepatitis, and TB data to create maps, charts, and detailed reports, and analyze trends and patterns.